Isolating CEST from MT Asymmetry in MRI

将 CEST 与 MRI 中的 MT 不对称性隔离

• 批准号: 8528923
• 负责人: ALEXEJ JERSCHOW
• 金额: $ 34.06万
• 依托单位: NEW YORK UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-06-01 至 2017-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8528923
• 关键词: Address; Appearance; Area; Biodistribution; Biological Markers; Biological Models; Brain; Cartilage; Chemicals; Chondroitin Sulfates; Concentration measurement; Contrast Media; Data; Degenerative polyarthritis; Development; Diagnostic; Disease; Frequencies; Functional disorder; Gel; Gelatin; Genes; Glioma; Glycosaminoglycans; Health; Image; Intervertebral disc structure; Lead; Link; Liquid substance; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Measurement; Measures; Metabolism; Methodology; Methods; Modification; Molecular Structure; Monitor; Muscle; NMR Spectroscopy; Neurotransmitters; Non-Insulin-Dependent Diabetes Mellitus; Patients; Predisposition; Procedures; Process; Protocols documentation; Protons; Research; Research Personnel; Sampling; Sepharose; Signal Transduction; Simulate; Sodium; Specimen; Spectrum Analysis; Techniques; Technology; Testing; Tissues; Validation; Water; base; diagnostic accuracy; in vivo; irradiation; new technology; operation; tool

DESCRIPTION (provided by applicant): Chemical exchange saturation transfer (CEST) MRI is a relatively new technology, and has become a vigorous research field where new contrast mechanisms are constantly being developed. Examples of this technology include the measurement of in vivo metabolite, neurotransmitter, and contrast agent concentrations, the measurement of in vivo pH, and the development of biomarkers for disorders such as glioma, osteoarthritis, muscle dysfunction, and type 2 diabetes. CEST contrast promises the ability to measure small concentrations of molecules via the large bulk water pool, hence with largely enhanced sensitivity. The major obstacles to widespread implementation of CEST MRI remain (1) the appearance of magnetization transfer (MT) asymmetry, and (2) the susceptibility to B0 field inhomogeneities, both of which can lead to false positives and false negatives. MT asymmetry arises from exchangeable protons or through-space magnetization transfer processes between immobile macromolecular structures and bulk water, and is a strong effect in many tissues including cartilage, muscle, and the brain. This proposal aims at 'decoupling' MT asymmetry from CEST entirely and directly, via the implementation of a new strategy: the investigators have recently discovered that broad resonances in tissues can be efficiently saturated via properly-placed simultaneous two-frequency irradiation and that MT asymmetry can be saturated efficiently and uniformly in CEST (2frequCEST). The MT saturation process does not rely on subtraction or the linearity of the MT effect. In addition, problem (2) will be addressed by using adapted B0 correction protocols with this new methodology. The primary testing ground of this approach will be the glycosaminoglycan (GAG) assessment in cartilage. This strategy is in itself very important for the development of early markers for osteoarthritis. The investigators have acquired considerable expertise in this field, both with gagCEST and sodium MRI methodology. The overall hypothesis is that two-frequency CEST provides better diagnostic ability than conventional CEST due to efficient elimination of MT asymmetry. The correlation will be assessed via MR spectroscopy (N-acetyl signal of GAG) and sodium MRI. The strategy is broken down into three specific aims: (1) Develop, quantify, and simulate 2frequCEST ex vivo, (2) Validate 2frequCEST with sodium content via microimaging ex vivo (sodium MR has been shown to be an efficient marker for GAG concentration in vivo). (3) Validate 2frequCEST with fluid-suppressed 23Na MRI on 3T/7T scanners in vivo. Successful completion of this project will provide a powerful proton-based diagnostic tool for devising effective monitoring strategies for osteoarthritis, but also potentially for many other disorders, such as muscle dysfunction, type 2 diabetes, as well as for the in vivo monitoring of metabolism and other diagnostic tasks where isolation of CEST from MT asymmetry is required.

描述(申请人提供)：化学交换饱和转移(CEST)MRI是一项相对较新的技术，已成为一个活跃的研究领域，新的造影剂机制正在不断开发。这项技术的例子包括体内代谢物、神经递质和造影剂浓度的测量，体内pH的测量，以及胶质瘤、骨关节炎、肌肉功能障碍和2型糖尿病等疾病的生物标记物的开发。CEST对比度保证了通过大型水池测量小分子浓度的能力，因此具有极大的增强的灵敏度。CEST MRI广泛应用的主要障碍是(1)磁化传递(MT)不对称性的出现，(2)对B0场不均匀的敏感性，这两者都可能导致假阳性和假阴性。MT的不对称性是由于固定的大分子结构与大块水之间可交换的质子或跨空间磁化转移过程而引起的，在软骨、肌肉和脑等许多组织中都有很强的影响。这一建议旨在通过实施一种新的策略，完全和直接地将MT不对称从CEST中分离出来：研究人员最近发现，通过适当的位置同时进行双频照射，组织中的广泛共振可以有效地饱和，并且MT不对称可以在CEST中高效和均匀地饱和(2频率CEST)。MT饱和过程不依赖于MT效应的减法或线性。此外，问题(2)将通过使用这一新方法的适应的B0校正协议来解决。这一方法的主要测试基础将是软骨中的糖胺多聚糖(GAG)评估。这一策略本身对骨性关节炎早期标志物的发展非常重要。研究人员在这一领域获得了相当多的专业知识，包括gagCEST和钠磁共振成像方法。总体假设是，由于有效地消除了MT的不对称性，双频CEST提供了比传统CEST更好的诊断能力。这种相关性将通过磁共振波谱(GAG的N-乙酰信号)和钠核磁共振进行评估。该策略可分解为三个具体目标：(1)体外建立、量化和模拟2频率CEST；(2)通过体外显微成像验证2频率CEST(钠MR已被证明是体内GAG浓度的有效标记物)。(3)在3T/7T扫描仪上用液体抑制的~(23)Na磁共振对2fCEST进行体内验证。这个项目的成功完成将提供一个强大的基于质子的诊断工具，用于设计有效的骨关节炎监测策略，也可能用于许多其他疾病，如肌肉功能障碍、2型糖尿病，以及体内代谢监测和其他需要将CEST从MT不对称中分离出来的诊断任务。